RESMED INC — Director's Dealing 2017

Feb 21, 2017

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: RESMED INC (RMD)
CIK: 0000943819
Period of Report: 2017-02-20

Reporting Person: ROBERTS CHRISTOPHER G (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2017-02-20	ResMed Common Stock	S	10000	$71.91	Disposed	313900	Indirect

Holdings (Non-Derivative)

Security	Shares	Ownership
ResMed Common Stock	145610	Direct
ResMed Common Stock	136000	Indirect
ResMed Common Stock	23200	Indirect

Footnotes

F1: Trade executed as CDI on Australian Securities Exchange converted at 10:1.

F2: ASX sale price average of A$ 9.3715 was converted using the foreign exchange rate on the transaction date of 1 AUD to .76743 USD. Trade was executed in multiple trades ranging in from A$ 9.37 to A$ 9.40 or USD 71.90 to 72.13.